Hospital officials said the technology customizes X-rays to conform to a tumor’s shape and destroy cancer cells while sparing surrounding normal tissue.
The new equipment allows for several advanced treatment approaches, including intensity modulated radiotherapy, image guided radiotherapy, volumetric arc therapy and stereotactic body radiation therapy.
“Today we begin a more advanced approach to the care, treatment and safety of cancer patients,” Karen Vadyak, CNO and assistant CEO, said in a prepared statement. “The new LINAC reduces treatment time and targets tumors with greater accuracy. We are pleased to offer this technology to patients who face the challenges of a cancer journey.”
More articles about supply chain:
Pills laced with fentanyl invade drug market
The shortage continues: Red Cross desperate for blood donations
FDA provides guidance for medical device tracking: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
